Table 2: Preoperative clinical characteristics in patients with cystic and solid VS: Symptom duration and frequency of low nerves dysfunction is statistically significant in patients with cystic VS.
|
Characteristics |
CVS (n = 12) |
SVS (n = 32) |
P value |
|
Distribution |
12 (27, 2%) |
32 (72, 8%) |
|
|
Age (years) |
26-70 |
21-74 |
0.136 |
|
Sex |
|||
|
Females |
07 (58, 5%) |
23 (71, 87%) |
< 0.001 |
|
Males |
05 (41, 5%) |
09 (28, 12%) |
< 0.001 |
|
Clinical characteristics |
|||
|
Symptom duration |
21 months |
37 months |
0.004 |
|
Hearing loss |
10 (83%) |
17 (53, 12%) |
0.303 |
|
Vertigo |
03 (25%) |
05 (24%) |
0.041 |
|
Tinnitus |
00 |
02 (10%) |
1.000 |
|
Facial nerve palsy |
06 (50%) |
20 (62, 5%) |
0.506 |
|
Trigeminal palsy |
10 (83, 33%) |
23 (71, 87%) |
0.658 |
|
low nerves dysfunction |
08 (66, 67%) |
08 (25%) |
0.016 |
|
Nystagmus |
03 (25%) |
07 (21, 87%) |
0.687 |
|
Cerebellar dysfunction |
08 (66, 67%) |
21 (65, 62%) |
1.000 |
|
intracranial hypertension |
04 (33, 33%) |
08 (25%) |
0.707 |
|
Deficit |
03 (25%) |
16 (50%) |
0.192 |
|
CSF shunt |
04 (33, 33%) |
08 (25%) |
0.707 |
CVS: Cystic Vestibular Schwanomma; SVS: Solid Vestibular Schwanomma; CSF: Cerebro Spinal Fluid